APA (7th ed.) Citation

Cosgrave, D., McNicholas, B., Hanley, C., Sheehan, J. R., Calpin, P., Kernan, M., . . . O'Toole, D. (2025). Can nebulised heparin reduce acute lung injury in patients with SARS‑CoV‑2 requiring advanced respiratory support in Ireland: The CHARTER‑Ireland phase Ib/IIa, randomised, parallel-group, open-label study. Intensive Care Medicine Experimental, 13(1), 1. https://doi.org/10.1186/s40635-025-00727-x

Chicago Style (17th ed.) Citation

Cosgrave, David, et al. "Can Nebulised Heparin Reduce Acute Lung Injury in Patients with SARS‑CoV‑2 Requiring Advanced Respiratory Support in Ireland: The CHARTER‑Ireland Phase Ib/IIa, Randomised, Parallel-group, Open-label Study." Intensive Care Medicine Experimental 13, no. 1 (2025): 1. https://doi.org/10.1186/s40635-025-00727-x.

MLA (9th ed.) Citation

Cosgrave, David, et al. "Can Nebulised Heparin Reduce Acute Lung Injury in Patients with SARS‑CoV‑2 Requiring Advanced Respiratory Support in Ireland: The CHARTER‑Ireland Phase Ib/IIa, Randomised, Parallel-group, Open-label Study." Intensive Care Medicine Experimental, vol. 13, no. 1, 2025, p. 1, https://doi.org/10.1186/s40635-025-00727-x.